[go: up one dir, main page]

FI943929L - Hepatiitti C-viruspeptidejä - Google Patents

Hepatiitti C-viruspeptidejä Download PDF

Info

Publication number
FI943929L
FI943929L FI943929A FI943929A FI943929L FI 943929 L FI943929 L FI 943929L FI 943929 A FI943929 A FI 943929A FI 943929 A FI943929 A FI 943929A FI 943929 L FI943929 L FI 943929L
Authority
FI
Finland
Prior art keywords
hepatitis
virus peptides
peptides
virus
Prior art date
Application number
FI943929A
Other languages
English (en)
Swedish (sv)
Other versions
FI943929A7 (fi
FI943929A0 (fi
Inventor
Ian Pike
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI943929L publication Critical patent/FI943929L/fi
Publication of FI943929A7 publication Critical patent/FI943929A7/fi
Publication of FI943929A0 publication Critical patent/FI943929A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI943929A 1992-02-28 1993-02-26 Hepatiitti C-viruspeptidejä FI943929A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204274A GB9204274D0 (en) 1992-02-28 1992-02-28 Novel peptides
PCT/GB1993/000410 WO1993017111A1 (en) 1992-02-28 1993-02-26 Hepatitis c virus peptides

Publications (3)

Publication Number Publication Date
FI943929L true FI943929L (fi) 1994-08-26
FI943929A7 FI943929A7 (fi) 1994-08-26
FI943929A0 FI943929A0 (fi) 1994-08-26

Family

ID=10711198

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943929A FI943929A0 (fi) 1992-02-28 1993-02-26 Hepatiitti C-viruspeptidejä

Country Status (10)

Country Link
EP (1) EP0628079A1 (fi)
JP (1) JPH07504562A (fi)
AU (1) AU688259B2 (fi)
CA (1) CA2131028A1 (fi)
CZ (1) CZ285834B6 (fi)
FI (1) FI943929A0 (fi)
GB (1) GB9204274D0 (fi)
SK (1) SK103594A3 (fi)
WO (1) WO1993017111A1 (fi)
ZA (1) ZA931299B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711670B1 (fr) * 1993-10-22 1996-01-12 Pasteur Institut Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
EP0829488A4 (en) * 1995-04-28 1999-04-07 Srl Inc ANTIGENIC PEPTIDE SUBSTANCE AND IMMOTEST PROCEDURE
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
CA2316130A1 (en) * 1999-08-19 2001-02-19 Masanori Fukui Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211772T1 (de) * 1989-05-18 2002-01-15 Chiron Corp Nanbv-diagnostika: polynukleotide, geeignet für reihenuntersuchungen auf hepatitis c-virus
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
JP3516681B2 (ja) * 1991-06-24 2004-04-05 カイロン コーポレイション Ｃ型肝炎ウイルス（ｈｃｖ）ポリペプチド

Also Published As

Publication number Publication date
CZ285834B6 (cs) 1999-11-17
SK103594A3 (en) 1995-06-07
EP0628079A1 (en) 1994-12-14
WO1993017111A1 (en) 1993-09-02
CA2131028A1 (en) 1993-09-02
AU688259B2 (en) 1998-03-12
JPH07504562A (ja) 1995-05-25
CZ206894A3 (en) 1995-03-15
AU3572593A (en) 1993-09-13
GB9204274D0 (en) 1992-04-08
ZA931299B (en) 1993-10-13
FI943929A7 (fi) 1994-08-26
FI943929A0 (fi) 1994-08-26

Similar Documents

Publication Publication Date Title
FI935808L (fi) Hepatit-C-virus (HCV) polypeptider
FI924349L (fi) Antigenkombinationer av hepatit c virus (hcv) foer anvaendning i immunobestaemningar av anti hcv motkroppar
ATA902590A (de) Rekombinantes pockenvirus
FI941199L (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
ATE209045T1 (de) Hepatitis b impfstoff
KR960703604A (ko) C형 간염 바이러스 증식 억제제(Hepatitis C Virus Proliferation Inhibitor)
DE4393381T1 (de) Peptide
FI942369L (fi) Hepatitis-C-virustesti
FI931801L (fi) Peptid-inhibitorer av hi-virusreplikation
DK0517292T3 (da) Rekombinant Avipox-virus
FI930582L (fi) Nanb-diagnostik: i screening av hepatit c virus anvaendbara polynukleotider
FI950567A7 (fi) Hepatitis A-virusrokote
FI952574A7 (fi) Glykosyylitransferaasiaktiiviset proteiinit
FI955224L (fi) Hepatiitti-C-virustyypit 4,5 ja 6
FI941758L (fi) Rekombitooppipeptidejä
DK132892D0 (da) Proteiner
DE69329145D1 (de) Anti-virale Fusionspeptide
AU5679394A (en) Hepatitis b virus vaccines
FI934777A7 (fi) Multipel hepatitis b virus ytproteiner som bildar partiklar
FI925876L (fi) Foerfarande foer framstaellning av ett virusinaktiverat protrombinkomplexkoncentrat
NO943540D0 (no) Antivirale peptider
FI943929L (fi) Hepatiitti C-viruspeptidejä
FI942184L (fi) Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita
NO933600D0 (no) Termostabile virus
FI932479L (fi) Rekombinant-insekt-virus med minskad kapacitet foer vaerd-till-vaerd-transmission i omgivningen och metoder foer framstaellning av detta virus